197 related articles for article (PubMed ID: 30038391)
1. Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients.
Edman MC; Janga SR; Meng Z; Bechtold M; Chen AF; Kim C; Naman L; Sarma A; Teekappanavar N; Kim AY; Madrigal S; Singh S; Ortiz E; Christianakis S; Arkfeld DG; Mack WJ; Heur M; Stohl W; Hamm-Alvarez SF
Sci Rep; 2018 Jul; 8(1):11044. PubMed ID: 30038391
[TBL] [Abstract][Full Text] [Related]
2. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
4. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome.
Regmi SC; Samsom ML; Heynen ML; Jay GD; Sullivan BD; Srinivasan S; Caffery B; Jones L; Schmidt TA
Exp Eye Res; 2017 Aug; 161():1-9. PubMed ID: 28549901
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
8. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
9. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
Fu R; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
[TBL] [Abstract][Full Text] [Related]
10. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren's syndrome-associated dry eye.
Zhou L; Wei R; Zhao P; Koh SK; Beuerman RW; Ding C
Proteomics; 2013 Aug; 13(16):2469-81. PubMed ID: 23733261
[TBL] [Abstract][Full Text] [Related]
13. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
[TBL] [Abstract][Full Text] [Related]
14. Novel Cytokine Multiplex Assay for Tear Fluid Analysis in Sjogren's Syndrome.
Willems B; Tong L; Minh TDT; Pham ND; Nguyen XH; Zumbansen M
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1639-1644. PubMed ID: 32657632
[No Abstract] [Full Text] [Related]
15. Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome.
Shinzawa M; Dogru M; Den S; Ichijima T; Higa K; Kojima T; Seta N; Nomura T; Tsubota K; Shimazaki J
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400384
[TBL] [Abstract][Full Text] [Related]
16. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
17. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.
Klinngam W; Fu R; Janga SR; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423938
[TBL] [Abstract][Full Text] [Related]
19. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
20. Abnormal protein profiles in tears with dry eye syndrome.
Ohashi Y; Ishida R; Kojima T; Goto E; Matsumoto Y; Watanabe K; Ishida N; Nakata K; Takeuchi T; Tsubota K
Am J Ophthalmol; 2003 Aug; 136(2):291-9. PubMed ID: 12888052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
